Grant: Collaborative Health Research Projects
University of British Columbia
$54,988.00
Making the connection: Methods to infer functional connectivity in brain studies
EF 2007-08
Résumé
In Parkinson's disease (PD), a common neurodegenerative disorder, there is discordance between brain cell loss and clinical disability because substantial compensatory mechanisms occur in PD, minimizing overall impairment. Thus measures of altered brain activity in PD are a product of both disease and compensatory processes, and disentangling these effects, while vital for understanding the mechanisms of disability, remains a challenge. As there is increasing evidence that normal and diseased brain functioning differ by altered patterns of dynamic connectivity between brain regions, it is critical to develop models assessing connectivity using current technologies available for non-invasively assessing PD subjects, i.e. fMRI and EEG. Our specific aims are to isolate disease effects from compensatory mechanisms and to determine the effects of medication (L-Dopa) in PD across 3 main domains: Connectivity, Spatial Extent of Activity, and Temporal Dynamics. This joint initiative between UBC, SFU and UNC represents a new collaboration between clinician-scientists treating and performing fMRI research in PD (Drs. McKeown and Huang); scientists with expertise in brain segmentation and shape analysis (Drs. Abugharbieh and Beg), as well as network modeling & statistical inference (Dr. Wang). The proposed research consists of the following technical components: 1.) Extend the newly developed dynamic causal models (DCM) for brain effective connectivity; 2.) Provide quantitative analysis of the spatial characteristics of fMRI activation; 3.) Determine the sensitivity of network models to mis-specification of manually-drawn regions of interest; and 4.) Expand Blind Source Separation (BSS) methods to the EEG data to infer transient synchronization between brain areas. This cross-disciplinary research effort has significant impact because it will advance understanding of both disease progression and the compensatory changes, and the developed methods will be widely applicable to other brain diseases. Also, the Canadian pharmaceutical industry would substantially benefit from a means to differentiate between neuroprotective and symptomatic effects of novel therapies.
Programme
Collaborative Health Research Projects
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
323602-2006
Name nom
McKeown, Martin
Department département
Medicine, Faculty of
Organization id
2
Institution établissement
University of British Columbia
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2007
Competition year année de concours
2006
Award amount
54988
Program id
CHRPJ
Program name en
Collaborative Health Research Projects
Program name fr
Projets de recherche concertée sur la santé
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
360
Committee name en
Collaborative Health Research Projects Selection Panel
Committee name fr
Comité de sélection de projets de recherche concertée sur la santé
Area of application code
1211
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Medical and health sciences
Area of application fr
Sciences médicales et de la santé
Research subject code
9000
Research subject group en
Medical sciences
Research subject group fr
Sciences médicales
Research subject en
Medical sciences
Research subject fr
Sciences médicales
Partie
2
Nb partie
3
Application title
Making the connection: Methods to infer functional connectivity in brain studies
Keyword
NA
Application summary
In Parkinson's disease (PD), a common neurodegenerative disorder, there is discordance between brain cell loss and clinical disability because substantial compensatory mechanisms occur in PD, minimizing overall impairment. Thus measures of altered brain activity in PD are a product of both disease and compensatory processes, and disentangling these effects, while vital for understanding the mechanisms of disability, remains a challenge. As there is increasing evidence that normal and diseased brain functioning differ by altered patterns of dynamic connectivity between brain regions, it is critical to develop models assessing connectivity using current technologies available for non-invasively assessing PD subjects, i.e. fMRI and EEG. Our specific aims are to isolate disease effects from compensatory mechanisms and to determine the effects of medication (L-Dopa) in PD across 3 main domains: Connectivity, Spatial Extent of Activity, and Temporal Dynamics. This joint initiative between UBC, SFU and UNC represents a new collaboration between clinician-scientists treating and performing fMRI research in PD (Drs. McKeown and Huang); scientists with expertise in brain segmentation and shape analysis (Drs. Abugharbieh and Beg), as well as network modeling & statistical inference (Dr. Wang). The proposed research consists of the following technical components: 1.) Extend the newly developed dynamic causal models (DCM) for brain effective connectivity; 2.) Provide quantitative analysis of the spatial characteristics of fMRI activation; 3.) Determine the sensitivity of network models to mis-specification of manually-drawn regions of interest; and 4.) Expand Blind Source Separation (BSS) methods to the EEG data to infer transient synchronization between brain areas. This cross-disciplinary research effort has significant impact because it will advance understanding of both disease progression and the compensatory changes, and the developed methods will be widely applicable to other brain diseases. Also, the Canadian pharmaceutical industry would substantially benefit from a means to differentiate between neuroprotective and symptomatic effects of novel therapies.